U.S. Capital Wealth Advisors LLC Cuts Holdings in Nutrien Ltd. (NYSE:NTR)

U.S. Capital Wealth Advisors LLC lessened its stake in Nutrien Ltd. (NYSE:NTRFree Report) by 56.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,212 shares of the company’s stock after selling 30,831 shares during the period. U.S. Capital Wealth Advisors LLC’s holdings in Nutrien were worth $1,084,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Goodman Financial Corp lifted its holdings in shares of Nutrien by 4.6% in the 3rd quarter. Goodman Financial Corp now owns 253,860 shares of the company’s stock worth $12,201,000 after acquiring an additional 11,058 shares during the last quarter. CORDA Investment Management LLC. lifted its holdings in shares of Nutrien by 7.0% in the 3rd quarter. CORDA Investment Management LLC. now owns 494,745 shares of the company’s stock worth $23,777,000 after acquiring an additional 32,541 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Nutrien by 10.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,742,351 shares of the company’s stock worth $83,812,000 after acquiring an additional 157,932 shares during the last quarter. Cardinal Capital Management Inc. lifted its holdings in shares of Nutrien by 4.3% in the 3rd quarter. Cardinal Capital Management Inc. now owns 564,078 shares of the company’s stock worth $27,139,000 after acquiring an additional 23,117 shares during the last quarter. Finally, Stephens Inc. AR lifted its holdings in shares of Nutrien by 335.0% in the 3rd quarter. Stephens Inc. AR now owns 70,301 shares of the company’s stock worth $3,379,000 after acquiring an additional 54,138 shares during the last quarter. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on NTR. UBS Group boosted their price objective on shares of Nutrien from $51.00 to $53.00 and gave the stock a “neutral” rating in a report on Tuesday, January 28th. CIBC reiterated an “outperformer” rating and set a $55.00 price target (down from $60.00) on shares of Nutrien in a report on Tuesday, December 10th. Piper Sandler upped their price target on shares of Nutrien from $58.00 to $63.00 and gave the company an “overweight” rating in a report on Monday, January 27th. JPMorgan Chase & Co. upgraded shares of Nutrien from an “underweight” rating to a “neutral” rating and upped their price target for the company from $40.00 to $50.00 in a report on Monday, January 13th. Finally, Wells Fargo & Company upped their price target on shares of Nutrien from $52.00 to $53.00 and gave the company an “equal weight” rating in a report on Tuesday, January 28th. One analyst has rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $58.94.

Read Our Latest Research Report on NTR

Nutrien Stock Up 3.7 %

NYSE:NTR opened at $52.86 on Wednesday. The firm’s 50-day moving average price is $48.31 and its 200-day moving average price is $48.05. The company has a market capitalization of $25.96 billion, a PE ratio of 35.48, a P/E/G ratio of 1.16 and a beta of 0.81. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. Nutrien Ltd. has a 1-year low of $43.69 and a 1-year high of $60.87.

Nutrien (NYSE:NTRGet Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.04). Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The firm had revenue of $5.35 billion for the quarter, compared to analysts’ expectations of $5.26 billion. During the same period last year, the company posted $0.35 earnings per share. The business’s revenue for the quarter was down 5.0% compared to the same quarter last year. On average, equities analysts predict that Nutrien Ltd. will post 3.49 EPS for the current fiscal year.

Nutrien Company Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Articles

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.